Rick E. Winningham

Insider Reports History

Reporting-owner location: South San Francisco, CA
Latest reporting-owner signature: By: /s/Paz Dizon, as attorney in fact For: Rick E. Winningham
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Rick E. Winningham

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Theravance Biopharma, Inc.

Security class: Ordinary Shares
Shares / value: 1,631,056
Estimated value: $26,472,038
Report date: 20 May 2026
Price: $16.23
Ownership: Direct

Form 4 holding Director

Jazz Pharmaceuticals plc

Security class: Ordinary Shares
Shares / value: 9,567
Estimated value: $2,311,100
Report date: 22 May 2026
Price: $241.57
Ownership: Direct

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Theravance Biopharma, Inc.

Security class: Ordinary Shares
Shares / value: 92,567
Estimated value: $1,502,362
Report date: 20 May 2026
Price: $16.23
Ownership: By Trust

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Theravance Biopharma, Inc.

Security class: Ordinary Shares
Shares / value: 23,400
Estimated value: $379,782
Report date: 20 May 2026
Price: $16.23
Ownership: As Custodian

Form 4 holding Director

Jazz Pharmaceuticals plc

Security class: Non-Qualified Stock Option (right to buy)
Shares / value: 0
Estimated value
Report date: 22 May 2026
Price
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount

Insider Reports Filed by Rick E. Winningham

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 22 May 2026
Transactions: 3
Transaction value: -$662,143
Accepted by SEC: 27 May 2026, 18:13
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 May 2026, 18:27
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 01 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Apr 2026, 18:10
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Feb 2026
Transactions: 1
Transaction value: -$1,474,008
Accepted by SEC: 24 Feb 2026, 19:43
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 19 Nov 2025
Transactions: 3
Transaction value: -$1,017,024
Accepted by SEC: 21 Nov 2025, 19:10
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 18 Nov 2025
Transactions: 1
Transaction value: -$994,728
Accepted by SEC: 20 Nov 2025, 17:54
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Aug 2025
Transactions: 1
Transaction value: -$206,126
Accepted by SEC: 22 Aug 2025, 18:09
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 07 Aug 2025
Transactions: 2
Transaction value: -$200,811
Accepted by SEC: 11 Aug 2025, 17:34
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 23 Jun 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 25 Jun 2025, 18:06
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 13 Jun 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 17 Jun 2025, 18:16
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 May 2025
Transactions: 1
Transaction value: -$145,190
Accepted by SEC: 22 May 2025, 18:44
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 28 Feb 2025
Transactions: 1
Transaction value: +$20,364
Accepted by SEC: 04 Mar 2025, 18:17
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Feb 2025
Transactions: 1
Transaction value: -$339,346
Accepted by SEC: 24 Feb 2025, 19:32
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Nov 2024
Transactions: 1
Transaction value: -$159,490
Accepted by SEC: 22 Nov 2024, 18:10
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 14 Nov 2024
Transactions: 1
Transaction value: +$30,557
Accepted by SEC: 19 Nov 2024, 21:08
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Aug 2024
Transactions: 1
Transaction value: -$131,495
Accepted by SEC: 22 Aug 2024, 20:09
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 07 Aug 2024
Transactions: 1
Transaction value: +$25,463
Accepted by SEC: 09 Aug 2024, 18:05
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 02 Aug 2024
Transactions: 2
Transaction value: -$165,243
Accepted by SEC: 06 Aug 2024, 18:42
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 May 2024
Transactions: 1
Transaction value: -$145,573
Accepted by SEC: 22 May 2024, 18:10
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 15 May 2024
Transactions: 1
Transaction value: +$20,370
Accepted by SEC: 17 May 2024, 18:01
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 02 Apr 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Apr 2024, 18:17
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 15 Mar 2024
Transactions: 4
Transaction value: +$23,363
Accepted by SEC: 19 Mar 2024, 18:06
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Feb 2024
Transactions: 1
Transaction value: -$331,788
Accepted by SEC: 22 Feb 2024, 20:14
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Nov 2023
Transactions: 1
Transaction value: -$163,887
Accepted by SEC: 22 Nov 2023, 18:16
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Aug 2023
Transactions: 1
Transaction value: -$153,299
Accepted by SEC: 22 Aug 2023, 18:19
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 11 Aug 2023
Transactions: 2
Transaction value: -$171,455
Accepted by SEC: 15 Aug 2023, 18:08
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 May 2023
Transactions: 1
Transaction value: -$177,163
Accepted by SEC: 23 May 2023, 19:48
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 01 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Mar 2023, 19:41
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Feb 2023
Transactions: 1
Transaction value: -$390,665
Accepted by SEC: 22 Feb 2023, 18:29
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 14 Dec 2022
Transactions: 2
Transaction value: -$559,500
Accepted by SEC: 16 Dec 2022, 18:36
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Nov 2022
Transactions: 1
Transaction value: -$171,473
Accepted by SEC: 22 Nov 2022, 15:09
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 19 Aug 2022
Transactions: 1
Transaction value: -$147,609
Accepted by SEC: 23 Aug 2022, 19:03
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 05 Aug 2022
Transactions: 2
Transaction value: -$165,879
Accepted by SEC: 09 Aug 2022, 18:52
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 May 2022
Transactions: 1
Transaction value: -$96,358
Accepted by SEC: 24 May 2022, 19:19
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 25 Feb 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 01 Mar 2022, 18:18
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 18 Feb 2022
Transactions: 1
Transaction value: -$218,243
Accepted by SEC: 23 Feb 2022, 17:38
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 19 Nov 2021
Transactions: 1
Transaction value: -$95,337
Accepted by SEC: 23 Nov 2021, 19:20
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 Aug 2021
Transactions: 1
Transaction value: -$160,226
Accepted by SEC: 24 Aug 2021, 19:05
Role: Chief Executive Officer, Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 06 Aug 2021
Transactions: 1
Transaction value: -$193,236
Accepted by SEC: 10 Aug 2021, 17:42
Role: Director
Next action: Open filing details

4 JAZZ

Jazz Pharmaceuticals plc

Report period: 29 Jul 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Aug 2021, 18:29
Role: Director
Next action: Open filing details

4 TBPH

Theravance Biopharma, Inc.

Report period: 20 May 2021
Transactions: 1
Transaction value: -$202,991
Accepted by SEC: 24 May 2021, 18:19
Role: Chief Executive Officer, Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Rick E. Winningham

Insider Reports Filed by Rick E. Winningham